Aditya Bahl

Mr. Bahl brings over 20 years of experience in pharmaceutical marketing and clinical development. He is the CEO and founder of RAS LSS, a boutique healthcare consulting group based in Germany providing strategic guidance to biotechnology and pharmaceutical companies on franchise and product strategy, clinical development and commercialization.

Mr. Bahl, who worked as Director of Competitive Intelligence at Novartis Pharma AG and as Senior Consultant for Janssen Research and Development, is known for his entrepreneurship, creativity and is a passionate speaker for innovations in healthcare. He has significant leadership experience across several therapeutic areas, including oncology and biosimilars.